BEONE MEDICINES LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value

BEONE MEDICINES LTD. (ONC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $55.95 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26

BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $55.95M, a 18.22% decline from fiscal 2024.
BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $68.42M, a 11.94% increase from fiscal 2023.
BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $61.12M, a 2.28% decline from fiscal 2022.
BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $62.55M, a 16.76% increase from fiscal 2021.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month
2025-12-31	$55.95M 10-K · filed 2026-02-26
2024-12-31	$68.42M 10-K · filed 2026-02-26
2023-12-31	$61.12M 10-K · filed 2026-02-26
2022-12-31	$62.55M 10-K · filed 2025-02-27
2021-12-31	$53.57M 10-K · filed 2024-02-26
2020-12-31	$55.13M 10-K · filed 2023-02-27
2019-12-31	$58.67M 10-K · filed 2022-02-28
2018-12-31	$55.64M 10-K · filed 2021-02-25
2017-12-31	$20.44M 10-K · filed 2020-03-02
2016-12-31	$2.82M 10-K · filed 2019-02-28